BioSight
Sep 03, 2019
Helsinn out licenses Pracinostat in South America
Helsinn Group grants exclusive licensing rights to Blanver and Varifarma for its leading drug Pracinostat in South America. Helsinn is a Swiss biopharmaceutical company committed to producing the best solutions aimed at improving the quality of life for people with cancer. Under the terms of the agreements, ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
